Susan Thomas, RN, joined Over the Counter to discuss women's health, the pharmacist's role, and her organization's newly launched program designed to benefit both patients and providers.

Jennifer Flynn, CPHRM, joined Over the Counter to discuss pharmacists' potential risks and benefits when using social media for professional or personal purposes.

Kenric B. Ware, PharmD, MBA, AAHIVP, joined Over the Counter to discuss stigmas surrounding HIV care and prevention as well as the pharmacist's role in advancing management of the condition.

Ron Lanton III, Esq, joined Over the Counter to discuss the Most Favored Nation drug pricing policy and what exactly it may mean for stakeholders heading into 2026.

Megan Smith, PharmD, joined Over the Counter to discuss continuously updated pneumococcal vaccines and the pharmacist's role among the greater health care community in managing pneumococcal diseases.

John C. Goodman, PhD, joined Over the Counter to discuss TrumpRx and this presidential administration's plans for lowering drug prices in the years to come.

Catie Stimmel, PharmD, joined Over the Counter to discuss the importance of patient safety organizations for the greater health care continuum.

Rick Sage, executive vice president of innovation and standards at NCPDP, joined Over the Counter to discuss the lasting impacts of the government shutdown on pharmacy and how it affected industry processes heading into 2026.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, joined Over the Counter to discuss both state and federal PBM reform heading into the new year.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, joined Over the Counter to discuss pharmacists' roles in improving diabetes outcomes as well as reaching patients in their communities.